Fenn C. Mathew

Array ( [id] => 1274027 [patent_doc_number] => 06645168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-11 [patent_title] => 'Arthroscopic irrigation solution and method for inhibition of pain and inflammation' [patent_app_type] => B2 [patent_app_number] => 10/195625 [patent_app_country] => US [patent_app_date] => 2002-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 27749 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645168.pdf [firstpage_image] =>[orig_patent_app_number] => 10195625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177969 [patent_doc_number] => 20020156075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents' [patent_app_type] => new [patent_app_number] => 10/107866 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10323 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156075.pdf [firstpage_image] =>[orig_patent_app_number] => 10107866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1341323 [patent_doc_number] => 06589985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-08 [patent_title] => 'Carbamate compounds for use in preventing or treating movement disorders' [patent_app_type] => B2 [patent_app_number] => 10/081501 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5283 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589985.pdf [firstpage_image] =>[orig_patent_app_number] => 10081501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736052 [patent_doc_number] => 20030013687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Pharmaceutical compositions and methods for treating anxiety, anxiety disorders and memory impairment using NAALADase inhibitors' [patent_app_type] => new [patent_app_number] => 10/077877 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13366 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013687.pdf [firstpage_image] =>[orig_patent_app_number] => 10077877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478976 [patent_doc_number] => 06451860 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Methods for treating depression and other disorders using optically pure ()-bupropion' [patent_app_type] => B1 [patent_app_number] => 10/076645 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5057 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451860.pdf [firstpage_image] =>[orig_patent_app_number] => 10076645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637069 [patent_doc_number] => 20020086864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Method of treating or preventing fibromyalgia and other somatoform disorders' [patent_app_type] => new [patent_app_number] => 10/037344 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9170 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086864.pdf [firstpage_image] =>[orig_patent_app_number] => 10037344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6438488 [patent_doc_number] => 20020128173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Method of treating or preventing migraine headaches' [patent_app_type] => new [patent_app_number] => 10/099334 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9136 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128173.pdf [firstpage_image] =>[orig_patent_app_number] => 10099334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968993 [patent_doc_number] => 20020091075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Treatment of depression' [patent_app_type] => new [patent_app_number] => 10/027135 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3784 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091075.pdf [firstpage_image] =>[orig_patent_app_number] => 10027135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278760 [patent_doc_number] => 06645967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-11 [patent_title] => 'Arylpiperazines having activity at the serotonin 1A receptor' [patent_app_type] => B2 [patent_app_number] => 10/022045 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17615 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645967.pdf [firstpage_image] =>[orig_patent_app_number] => 10022045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1401965 [patent_doc_number] => 06538034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-25 [patent_title] => 'Methods of treating or preventing weight gain, obesity, and related disorders' [patent_app_type] => B2 [patent_app_number] => 10/000806 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16218 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538034.pdf [firstpage_image] =>[orig_patent_app_number] => 10000806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575358 [patent_doc_number] => 06469046 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Indole compounds useful for treating bacterial infections' [patent_app_type] => B1 [patent_app_number] => 09/980304 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3784 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469046.pdf [firstpage_image] =>[orig_patent_app_number] => 09980304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1501093 [patent_doc_number] => 06486192 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Indole compounds useful for treating bacterial infections' [patent_app_type] => B1 [patent_app_number] => 09/980164 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3693 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486192.pdf [firstpage_image] =>[orig_patent_app_number] => 09980164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096992 [patent_doc_number] => 20020052382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'R-hydroxynefazodone' [patent_app_type] => new [patent_app_number] => 09/988935 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4911 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052382.pdf [firstpage_image] =>[orig_patent_app_number] => 09988935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361732 [patent_doc_number] => 20020058675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => '(R)-hydroxynefazodone antipsychotic therapy' [patent_app_type] => new [patent_app_number] => 09/992197 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6531 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058675.pdf [firstpage_image] =>[orig_patent_app_number] => 09992197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923424 [patent_doc_number] => 20020115703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Prevention of development of dyskinesias' [patent_app_type] => new [patent_app_number] => 09/987382 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3039 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115703.pdf [firstpage_image] =>[orig_patent_app_number] => 09987382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112934 [patent_doc_number] => 20020173547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Pharmaceuticals compositions' [patent_app_type] => new [patent_app_number] => 09/984020 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4753 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173547.pdf [firstpage_image] =>[orig_patent_app_number] => 09984020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1274592 [patent_doc_number] => 06649614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-18 [patent_title] => 'Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent for treatment of depression or anxiety' [patent_app_type] => B2 [patent_app_number] => 09/978437 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18295 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649614.pdf [firstpage_image] =>[orig_patent_app_number] => 09978437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1338202 [patent_doc_number] => 06593373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-15 [patent_title] => 'Pharmaceutical compositions of O-desmethyl-N-mono-desmethyl-tramadol' [patent_app_type] => B2 [patent_app_number] => 09/974886 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2624 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593373.pdf [firstpage_image] =>[orig_patent_app_number] => 09974886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360525 [patent_doc_number] => 06573281 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disorders' [patent_app_type] => B1 [patent_app_number] => 09/958439 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1579 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573281.pdf [firstpage_image] =>[orig_patent_app_number] => 09958439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514844 [patent_doc_number] => 06420388 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Osanetant in the treatment of depression and depressive disorders' [patent_app_type] => B1 [patent_app_number] => 09/958266 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 753 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420388.pdf [firstpage_image] =>[orig_patent_app_number] => 09958266 [rel_patent_id] =>[rel_patent_doc_number] =>)